Reazur Rasul - Mar 1, 2023 Form 4 Insider Report for BAXTER INTERNATIONAL INC (BAX)

Role
EVP, Group Pres, Healthcare
Signature
/s/ Mathew Rice, as attorney in-fact for Reaz Rasul
Stock symbol
BAX
Transactions as of
Mar 1, 2023
Transactions value $
$0
Form type
4
Date filed
3/3/2023, 03:10 PM
Next filing
Mar 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BAX Common Stock, $1 par value Award $0 +15.4K +127.99% $0.00 27.5K Mar 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BAX Stock Option (Right to Buy) Award $0 +64K $0.00 64K Mar 1, 2023 Common Stock, $1 par value 64K $39.06 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.
F2 The options become exercisable in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date.